chr2-229767552-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001348323.3(TRIP12):c.*2C>T variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.139 in 1,603,182 control chromosomes in the GnomAD database, including 16,287 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1906 hom., cov: 33)
Exomes 𝑓: 0.14 ( 14381 hom. )
Consequence
TRIP12
NM_001348323.3 3_prime_UTR
NM_001348323.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.66
Genes affected
TRIP12 (HGNC:12306): (thyroid hormone receptor interactor 12) The protein encoded by this gene is an E3 ubiquitin-protein ligase involved in the degradation of the p19ARF/ARF isoform of CDKN2A, a tumor suppressor. The encoded protein also plays a role in the DNA damage response by regulating the stability of USP7, which regulates tumor suppressor p53. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 2-229767552-G-A is Benign according to our data. Variant chr2-229767552-G-A is described in ClinVar as [Benign]. Clinvar id is 1181222.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIP12 | NM_001348323.3 | c.*2C>T | 3_prime_UTR_variant | 42/42 | ENST00000675903.1 | NP_001335252.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIP12 | ENST00000675903 | c.*2C>T | 3_prime_UTR_variant | 42/42 | NM_001348323.3 | ENSP00000502713.1 |
Frequencies
GnomAD3 genomes AF: 0.153 AC: 23221AN: 152120Hom.: 1905 Cov.: 33
GnomAD3 genomes
AF:
AC:
23221
AN:
152120
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.140 AC: 34111AN: 243326Hom.: 2684 AF XY: 0.134 AC XY: 17613AN XY: 131298
GnomAD3 exomes
AF:
AC:
34111
AN:
243326
Hom.:
AF XY:
AC XY:
17613
AN XY:
131298
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.137 AC: 199143AN: 1450944Hom.: 14381 Cov.: 31 AF XY: 0.135 AC XY: 97265AN XY: 720920
GnomAD4 exome
AF:
AC:
199143
AN:
1450944
Hom.:
Cov.:
31
AF XY:
AC XY:
97265
AN XY:
720920
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.153 AC: 23243AN: 152238Hom.: 1906 Cov.: 33 AF XY: 0.151 AC XY: 11207AN XY: 74446
GnomAD4 genome
AF:
AC:
23243
AN:
152238
Hom.:
Cov.:
33
AF XY:
AC XY:
11207
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
396
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
TRIP12-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at